Prosight Management’s Ovid Therapeutics OVID Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-729,208	Closed	-$860K	–	45
2024 Q3	$860K	Sell	729,208 -345,792	-32%	-$408K	0.21%	38
2024 Q2	$827K	Buy	1,075,000 +91,800	+9%	+$70.6K	0.25%	41
2024 Q1	$3M	Buy	+983,200	New	+$3M	0.83%	32